Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05382741
Title Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial (VIVA)
Acronym VIVA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ospedale Policlinico San Martino
Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST